, Hong Kong
215 views

Manulife partners with Prosper Health for cancer medication access

Eligible customers will have access to Manulife’s Personalised Medical Case Managers.

Manulife Hong Kong partnered with Prosper Health and Shenzhen New Frontier United Family Hospital to launch the "Cancer Drug Support Service.”

The press release said they are the first insurer to offer such a service.

The service allows eligible customers to connect with Manulife’s Personalised Medical Case Managers, who are qualified nurses with healthcare experience. 

These managers will verify the availability and cost of prescribed cancer medications at the hospital and coordinate initial consultations upon request. 

During the campaign period, eligible customers can also benefit from a complimentary door-to-door limousine service.  

Carrie Tong, COO of Manulife Hong Kong and Macau, emphasised that the service is designed to reduce cancer treatment expenses.  

Thom Gao, COO of Prosper Health, noted that the initiative builds on past successful collaborations and addresses the practical challenges of accessing oral cancer medications. 

Brian Siu, COO of New Frontier GBA, added that the collaboration leverages the hospital's medical resource integration to simplify the treatment process and enhance patient convenience.  
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.